Supportive psychotherapy + Psilocybin for major depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 10 Oct 2023: Trial registered, NCT06072898
  2. 28 May 2025: Trial started, NCT06072898

The trials

NCT06072898: A Randomized Neuroimaging Trial of Psilocybin in Depression

State
Under way
Phase
Phase 2
People
50 planned
Started
28 May 2025
Primary completion
May 2028
Arms
Staged Active Treatment Arm (Psilocybin-Psilocybin)
Results
None posted
  1. 10 Oct 2023: Trial registered
  2. 28 May 2025: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.